Naonori Harada
Overview
Explore the profile of Naonori Harada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
183
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Harada N, Hosaka N, Tsumura A
Transpl Infect Dis
. 2025 Jan;
e14438.
PMID: 39826144
No abstract available.
3.
Watanabe K, Harada N, Shibano I, Izuta Y, Mukai D, Kizawa Y, et al.
Rinsho Ketsueki
. 2024 Jun;
65(5):335-339.
PMID: 38825510
A 69-year-old woman was previously treated with antibiotics for suspected pyelonephritis due to fever but showed limited improvement. Contrast-enhanced CT revealed heterogeneous areas of decreased contrast enhancement in both kidneys,...
4.
Tazoe K, Harada N, Makuuchi Y, Kuno M, Takakuwa T, Okamura H, et al.
Ann Hematol
. 2024 Apr;
103(6):2059-2072.
PMID: 38662207
Myelodysplastic syndrome (MDS) is well known to be complicated by systemic inflammatory autoimmune disease (SIADs). However, it remains unclear how the prognosis after allogenic hematopoietic stem cell transplantation (allo-HSCT) in...
5.
Harada N, Shibano I, Izuta Y, Kizawa Y, Shiragami H, Tsumura A, et al.
J Infect Chemother
. 2024 Apr;
30(11):1182-1185.
PMID: 38570136
Epstein-Barr virus (EBV) reactivation in COVID-19 patients has been reported, but studies on its clinical significance are lacking. We herein report the occurrence of infectious mononucleosis (IM) due to EBV...
6.
7.
Okayama Y, Harada N, Makuuchi Y, Kuno M, Takakuwa T, Okamura H, et al.
Int J Hematol
. 2024 Jan;
119(3):316-326.
PMID: 38252235
Hepatomegaly is an extramedullary disease (EMD) manifestation of hematological malignancy. Although EMD before allogeneic hematopoietic stem cell transplantation (allo-HCT) is a risk factor for relapse in patients not in complete...
8.
Tazoe K, Harada N, Takemura K, Nakamae M, Hino M
Cureus
. 2023 Dec;
15(11):e48253.
PMID: 38054160
Hyperviscosity syndrome (HVS) is a complication of monoclonal plasma cell tumors. The frequency of HVS depends on the type of monoclonal protein. Immunoglobulin M (IgM) is more closely associated with...
9.
Harada N, Mukai D, Izuta Y, Shibano I, Kizawa Y, Shiragami H, et al.
Pathol Int
. 2023 Dec;
74(2):93-95.
PMID: 38050833
No abstract available.
10.
Harada N, Okamura H, Makuuchi Y, Kuno M, Takakuwa T, Nakamae M, et al.
Bone Marrow Transplant
. 2023 Sep;
58(12):1403-1405.
PMID: 37714944
No abstract available.